Skip to main content
SpringerLink
Log in

Presentation and Pathogenesis of Kaposi Sarcoma

  • Chapter
  • First Online:
Cancers in People with HIV and AIDS

  • 938 Accesses

Abstract

Kaposi sarcoma (KS) is a vascular neoplasm caused by infection with human herpesvirus 8 (HHV-8). Epidemic KS is found among persons with HIV infection; it is the most common malignancy in persons with HIV worldwide. Two decades after HHV-8 was first identified, much is now known about how chronic infection leads to the development of KS. HHV-8 is likely transmitted via saliva in most cases. The virus, host, and possibly environmental factors all contribute to the risk of developing KS. Heterogeneous clinical manifestations of the disease feature skin and mucous membrane involvement in adults, with advanced disease involving the thoracic or abdominal viscera. Pediatric KS is unusual outside of sub-Saharan Africa, but is typically characterized by lymph node and cutaneous disease. KS also may be the presenting manifestation of an immune reconstitution inflammatory syndrome after HIV-infected patients initiate antiretroviral therapy, and can be co-morbid with other HHV-8-associated diseases including multicentric Castleman disease and primary effusion lymphoma. For patients with access to ART and/or chemotherapy, survival after a diagnosis of KS is excellent, but clinical responses to therapy are often incomplete and new therapies for the disease are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, Saag MS. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS. 2011;25(5):691–700.

    Article  PubMed  Google Scholar 

  • Achenbach CJ, Harrington RD, Dhanireddy S, Crane HM, Casper C, Kitahata MM. Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection. Clin Infect Dis. 2012;54(3):424–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Andreoni M, Sarmati L, Nicastri E, El Sawaf G, El Zalabani M, Uccella I, Bugarini R, Parisi SG, Rezza G. Primary human herpesvirus 8 infection in immunocompetent children. JAMA. 2002;287(10):1295–300.

    Article  PubMed  Google Scholar 

  • Aoki Y, Tosato G. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood. 2004;104(3):810–4.

    Article  CAS  PubMed  Google Scholar 

  • Armenian HK, Hoover DR, Rubb S, Metz S, Kaslow R, Visscher B, Chmiel J, Kingsley L, Saah A. Composite risk score for Kaposi’s sarcoma based on a case–control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol. 1993;138(4):256–65.

    CAS  PubMed  Google Scholar 

  • Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H. Risk of Kaposi’s sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet. 1992;339(8794):632–5.

    Article  CAS  PubMed  Google Scholar 

  • Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99(12):962–72.

    Article  PubMed  Google Scholar 

  • Bihl F, Berger C, Chisholm 3rd JV, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ, Swiss HIV Cohort Study. Cellular immune responses and disease control in acute AIDS-associated Kaposi’s sarcoma. AIDS. 2009;23(14):1918–22.

    Article  PubMed  Google Scholar 

  • Browning PJ, Sechler JM, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC. Identification and culture of Kaposi’s sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood. 1994;84(8):2711–20.

    CAS  PubMed  Google Scholar 

  • Carroll PA, Brazeau E, Lagunoff M. Kaposi’s sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology. 2004;328(1):7–18.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Casper C, Redman M, Huang ML, Pauk J, Lampinen TM, Hawes SE, Critchlow CW, Morrow RA, Corey L, Kiviat N, Wald A. HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. J Acquir Immune Defic Syndr. 2004;35(3):233–8.

    Article  PubMed  Google Scholar 

  • Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect. 2006;82(3):229–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang ML, Wald A. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis. 2008;198(1):23–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cattamanchi A, Saracino M, Selke S, Huang ML, Magaret A, Celum C, Corey L, Wald A, Casper C. Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. J Med Virol. 2011;83(10):1696–703.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Center for Disease Control. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men–New York City and California. Morb Mortal Wkly Rep. 1981;30(25):305–8.

    Google Scholar 

  • Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266(5192):1865–9.

    Article  CAS  PubMed  Google Scholar 

  • Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science. 2002;298(5597):1432–5.

    Article  CAS  PubMed  Google Scholar 

  • Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi’s sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol. 2002;20(1): 153–9.

    Article  CAS  PubMed  Google Scholar 

  • Coluzzi M, Calabro ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V. Reduced seroprevalence of Kaposi’s sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol. 2003;17(4):461–4.

    Article  CAS  PubMed  Google Scholar 

  • Crane HM, Deubner H, Huang JC, Swanson PE, Harrington RD. Fatal Kaposi’s sarcoma-associated immune reconstitution following HAART initiation. Int J STD AIDS. 2005;16(1):80–3.

    Article  PubMed  Google Scholar 

  • Della Bella S, Taddeo A, Calabro ML, Brambilla L, Bellinvia M, Bergamo E, Clerici M, Villa ML. Peripheral blood endothelial progenitors as potential reservoirs of Kaposi’s sarcoma-associated herpesvirus. PLoS One. 2008;3(1):e1520.

    Article  PubMed Central  PubMed  Google Scholar 

  • Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi’s sarcoma: an AIDS malignancy consortium study. J Clin Oncol. 2006;24(9):1389–94.

    Article  CAS  PubMed  Google Scholar 

  • Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A, Dalens H, Rigal D, Djerbi R, Hadj Salah H, Belaid S, Achour H, Djerbi A, Mestiri S. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med. 1999;190(7):1025–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dollard SC, Butler LM, Jones AMG, Mermin JH, Chidzonga M, Chipato T, Shiboski CH, Brander C, Mosam A, Kiepiela P, Hladik W, Martin JN. Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the “Kaposi’s sarcoma belt”. Int J Cancer. 2010;127(10):2395–401.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Duus KM, Lentchitsky V, Wagenaar T, Grose C, Webster-Cyriaque J. Wild-type Kaposi’s sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol. 2004;78(8):4074–84.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. Detection and quantification of Kaposi’s sarcoma-associated herpesvirus to predict AIDS-associated Kaposi’s sarcoma. AIDS. 2003;17(12):1847–51.

    Article  PubMed  Google Scholar 

  • Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Retrieved 14 Jan 2014 from http://globocan.iarc.fr.

  • Fife K, Howard MR, Gracie F, Phillips RH, Bower M. Activity of thalidomide in AIDS-related Kaposi’s sarcoma and correlation with HHV8 titre. Int J STD AIDS. 1998;9(12):751–5.

    Article  CAS  PubMed  Google Scholar 

  • Gantt S, Kakuru A, Wald A, Walusansa V, Corey L, Casper C, Orem J. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010;54(5):670–4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Gondos A, Brenner H, Wabinga H, Parkin DM. Cancer survival in Kampala, Uganda. Br J Cancer. 2005;92(9):1808–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc Natl Acad Sci U S A. 2009;106(28):11725–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67.

    Article  PubMed  Google Scholar 

  • Grundhoff A, Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest. 2004;113(1):124–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hymes KB, Cheung T, Greene JB, Prose NS, Marcus A, Ballard H, William DC, Laubenstein LJ. Kaposi’s sarcoma in homosexual men-a report of eight cases. Lancet. 1981;2(8247):598–600.

    Article  CAS  PubMed  Google Scholar 

  • Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer. 2000;88(3):500–17.

    Article  CAS  PubMed  Google Scholar 

  • Johnston C, Orem J, Okuku F, Kalinaki M, Saracino M, Katongole-Mbidde E, Sande M, Ronald A, McAdam K, Huang ML, Drolette L, Selke S, Wald A, Corey L, Casper C. Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda. PLoS One. 2009;4(1):e4222.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kestens L, Melbye M, Biggar RJ, Stevens WJ, Piot P, De Muynck A, Taelman H, De Feyter M, Paluku L, Gigase PL. Endemic African Kaposi’s sarcoma is not associated with immunodeficiency. Int J Cancer. 1985;36(1):49–54.

    Article  CAS  PubMed  Google Scholar 

  • Kimball LE, Casper C, Koelle DM, Morrow R, Corey L, Vieira J. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. J Infect Dis. 2004;189(11):2016–22.

    Article  CAS  PubMed  Google Scholar 

  • Koon HB, Bubley GJ, Pantanowitz L, Masiello D, Smith B, Crosby K, Proper J, Weeden W, Miller TE, Chatis P, Egorin MJ, Tahan SR, Dezube BJ. Imatinib-induced regression of AIDS-related Kaposi’s sarcoma. J Clin Oncol. 2005;23(5):982–9.

    Article  CAS  PubMed  Google Scholar 

  • Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II Trial of Imatinib in AIDS-Associated Kaposi’s Sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014;32(5):402–8.

    Article  CAS  PubMed  Google Scholar 

  • Krown SE, Testa MA, Huang J. AIDS-related Kaposi’s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997;15(9):3085–92.

    CAS  PubMed  Google Scholar 

  • Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Roenn JH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr. 2006;41(2): 149–53.

    Article  CAS  PubMed  Google Scholar 

  • Krown SE, Dittmer DP, Cesarman E. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma. J Infect Dis. 2011;203(8):1082–6.

    Article  CAS  PubMed  Google Scholar 

  • Levine AM, Tulpule A, Quinn DI, Gorospe III G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006;24(11):1712–9.

    Article  CAS  PubMed  Google Scholar 

  • Little RF, Wyvill KM, Pluda JM, Welles L, Marshall V, Figg WD, Newcomb FM, Tosato G, Feigal E, Steinberg SM, Whitby D, Goedert JJ, Yarchoan R. Activity of thalidomide in AIDS-related Kaposi’s sarcoma. J Clin Oncol. 2000;18(13):2593–602.

    CAS  PubMed  Google Scholar 

  • Little RF, Merced-Galindez F, Staskus K, Whitby D, Aoki Y, Humphrey R, Pluda JM, Marshall V, Walters M, Welles L, Rodriguez-Chavez IR, Pittaluga S, Tosato G, Yarchoan R. A pilot study of cidofovir in patients with Kaposi sarcoma. J Infect Dis. 2003;187(1):149–53.

    Article  CAS  PubMed  Google Scholar 

  • Lu M, Suen J, Frias C, Pfeiffer R, Tsai M-H, Chuang E, Zeichner SL. Dissection of the Kaposi’s sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir. J Virol. 2004;78(24):13637–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lundquist A, Barre B, Bienvenu F, Hermann J, Avril S, Coqueret O. Kaposi’s sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood. 2003;101(10):4070–7.

    Article  CAS  PubMed  Google Scholar 

  • Luppi M, Barozzi P, Schulz TF, Setti G, Staskus K, Trovato R, Narni F, Donelli A, Maiorana A, Marasca R, Sandrini S, Torelli G, Sheldon J. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med. 2000;343(19):1378–85.

    Article  CAS  PubMed  Google Scholar 

  • Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 1998;338(14):948–54.

    Article  CAS  PubMed  Google Scholar 

  • Martin J, Laker M, Kambugu A, Janka D, Orem J, Mwaka A, Maurer T, Mbidde E. Kaposi’s sarcoma-associated immune reconstitution inflammatory syndrome (KS-IRIS) in Africa: initial findings from a prospective evaluation. Infect Agent Cancer. 2009;4 Suppl 2:O17.

    Article  Google Scholar 

  • Martinez V, Tateo M, Castilla MA, Melica G, Kirstetter M, Boue F. Lenalidomide in treating AIDS-related Kaposi’s sarcoma. AIDS. 2011;25(6):878–80.

    Article  PubMed  Google Scholar 

  • Maurer T, Ponte M, Leslie K. HIV-associated Kaposi’s sarcoma with a high CD4 count and a low viral load. N Engl J Med. 2007;357(13):1352–3.

    Article  CAS  PubMed  Google Scholar 

  • Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer. 2006;118(4):985–90.

    Article  CAS  PubMed  Google Scholar 

  • Mosam A, Shaik F, Uldrick TS, Esterhuizen T, Friedland GH, Scadden DT, Aboobaker J, Coovadia HM. A randomized controlled trial of HAART versus HAART and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr. 2012;60(2):150–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Azumi N, Kishishita M, Brady JN, Doniger J, Medveczky P, Rosenthal LJ. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) transforming gene. J Virol. 1998;72(6):4980–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Nasti G, Martellotta F, Berretta M, Mena M, Fasan M, Di Perri G, Talamini R, Pagano G, Montroni M, Cinelli R, Vaccher E, D’Arminio Monforte A, Tirelli U. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer. 2003;98(11):2440–6.

    Article  PubMed  Google Scholar 

  • Nguyen HQ, Magaret AS, Van Rompaey SE, Kitahata MM, Wald A, Casper C. Persistent Kaposi sarcoma in the era of HAART: characterizing the predictors of clinical response. AIDS. 2008;22(8):937–45.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Niedt GW, Prioleau PG. Kaposi’s sarcoma occurring in a dermatome previously involved by herpes zoster. J Am Acad Dermatol. 1988;18(2 Pt 2):448–51.

    Article  CAS  PubMed  Google Scholar 

  • Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR. Changing cancer incidence in Kampala, Uganda, 1991–2006. Int J Cancer. 2010;126(5):1187–95.

    CAS  PubMed  Google Scholar 

  • Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med. 2000;343(19):1369–77.

    Article  CAS  PubMed  Google Scholar 

  • Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, Meltzer P, Bittner M, Trent J, Zeichner S. Transcription program of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus). J Virol. 2001;75(10):4843–53.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, Orem J, Kambugu A, Casper C. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS One. 2010;5(11):e13936.

    Article  PubMed Central  PubMed  Google Scholar 

  • Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med. 2000;6(10):1121–7.

    Article  CAS  PubMed  Google Scholar 

  • Renne R, Lagunoff M, Zhong W, Ganem D. The size and conformation of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol. 1996;70(11):8151–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ribechini E, Fortini C, Marastoni M, Traniello S, Spisani S, Monini P, Gavioli R. Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8. J Immunol. 2006;176(2): 923–30.

    Article  CAS  PubMed  Google Scholar 

  • Sabbah S, Jagne YJ, Zuo J, de Silva T, Ahasan MM, Brander C, Rowland-Jones S, Flanagan KL, Hislop AD. T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells. Blood. 2012;119(9):2083–92.

    Article  CAS  PubMed  Google Scholar 

  • Schwarz M, Murphy PM. Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol. 2001;167(1):505–13.

    Article  CAS  PubMed  Google Scholar 

  • Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753–62.

    Article  PubMed Central  PubMed  Google Scholar 

  • Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, Rezza G, Monini P, Ensoli B. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi’s sarcoma. Eur J Immunol. 2002;32(10):2711–20.

    Article  CAS  PubMed  Google Scholar 

  • Soler RA, Howard M, Brink NS, Gibb D, Tedder RS, Nadal D. Regression of AIDS-related Kaposi’s sarcoma during therapy with thalidomide. Clin Infect Dis. 1996;23(3):501–3. discussion 504–505.

    Article  CAS  PubMed  Google Scholar 

  • Taddeo A, Presicce P, Brambilla L, Bellinvia M, Villa ML, Bella SD. Circulating endothelial progenitor cells are increased in patients with classic Kaposi’s sarcoma. J Invest Dermatol. 2008; 128(8):2125–8.

    Article  CAS  PubMed  Google Scholar 

  • Tamm M, Reichenberger F, McGandy CE, Stalder A, Tietz A, Dalquen P, Perruchoud AP, Cathomas G. Diagnosis of pulmonary Kaposi’s sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Respir Crit Care Med. 1998;157(2):458–63.

    Article  CAS  PubMed  Google Scholar 

  • Touloumi G, Hatzakis A, Potouridou I, Milona I, Strarigos J, Katsambas A, Giraldo G, Beth-Giraldo E, Biggar RJ, Mueller N, Trichopoulos D. The role of immunosuppression and immune-activation in classic Kaposi’s sarcoma. Int J Cancer. 1999;82(6):817–21.

    Article  CAS  PubMed  Google Scholar 

  • Uldrick TS, Wang V, O’Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease. Clin Infect Dis. 2010;51(3):350–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Uldrick TS, Wyvill KM, Kumar P, O’Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R. Phase II study of bevacizumab in patients with HIV-associated Kaposi’s sarcoma receiving antiretroviral therapy. J Clin Oncol. 2012;30(13):1476–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vieira J, O’Hearn P, Kimball L, Chandran B, Corey L. Activation of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol. 2001;75(3):1378–86.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wang QJ, Jenkins FJ, Jacobson LP, Meng YX, Pellett PE, Kingsley LA, Kousoulas KG, Baghian A, Rinaldo Jr CR. CD8+ cytotoxic T lymphocyte responses to lytic proteins of human herpes virus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals. J Infect Dis. 2000;182(3):928–32.

    Article  CAS  PubMed  Google Scholar 

  • Weber KS, Grone HJ, Rocken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol. 2001;31(8):2458–66.

    Article  CAS  PubMed  Google Scholar 

  • Weltfriend S, Friedman-Birnbaum R, Pollack S. Decreased natural killer cell function in patients with classical Kaposi’s sarcoma. Dermatologica. 1990;181(3):207–10.

    Article  CAS  PubMed  Google Scholar 

  • Ziegler JL. Endemic Kaposi’s sarcoma in Africa and local volcanic soils. Lancet. 1993;342(8883): 1348–51.

    Article  CAS  PubMed  Google Scholar 

  • Zong J, Ciufo DM, Viscidi R, Alagiozoglou L, Tyring S, Rady P, Orenstein J, Boto W, Kalumbuja H, Romano N, Melbye M, Kang GH, Boshoff C, Hayward GS. Genotypic analysis at multiple loci across Kaposi’s sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol. 2002;23(3):119–48.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vaccine and Infectious Disease, Public Health Sciences and Clinical Research Divisions, Departments of Medicine, Epidemiology and Global Health, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

    Corey Casper M.D., M.P.H.

Authors
  1. Corey Casper M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corey Casper M.D., M.P.H. .

Editor information

Editors and Affiliations

  1. National Cancer Institute HIV/AIDS Malignancy Branch, National Institutes of Health, Bethesda, Maryland, USA

    Robert Yarchoan

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Casper, C. (2014). Presentation and Pathogenesis of Kaposi Sarcoma. In: Yarchoan, R. (eds) Cancers in People with HIV and AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0859-2_9

Download citation

Publish with us

Policies and ethics

Search

Navigation